Public Employees Retirement Association Of Colorado Fibrogen Inc Transaction History

Public Employees Retirement Association Of Colorado

$25.2 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.79 - $2.83 $7,805 - $27,960	-9,880 Reduced 40.73%	14,377 $12,000
Q3 2023 Nov 14, 2023	BUY	$0.79 - $2.83 $7,805 - $27,960	9,880 Added 68.72%	24,257 $3.99 Million
Q2 2020 Aug 05, 2020	SELL	$32.57 - $42.83 $4,559 - $5,996	-140 Reduced 0.96%	14,377 $583,000
Q2 2019 Jul 31, 2019	SELL	$35.13 - $55.53 $243,486 - $384,878	-6,931 Reduced 32.32%	14,517 $656,000
Q1 2019 Apr 30, 2019	BUY	$42.83 - $59.91 $599,962 - $839,219	14,008 Added 188.28%	21,448 $1.17 Million
Q4 2017 Feb 02, 2018	BUY	$41.95 - $60.1 $312,108 - $447,144	7,440	7,440 $353,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement Association Of Colorado, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement Association Of Colorado with notifications on news.

Account